beta
Text
1. The plaintiff's claim is dismissed.
2. The costs of lawsuit shall be borne by the Plaintiff.
Reasons
1. Basic facts
(a) The name of the Defendant’s patented invention (Evidence A and 2) invention of this case subject to the registration for extension of the patent term: Csanic inducement and manufacturing method 2) international filing date/ initial priority claim/ translation submission date/registration date/registration date/registration number: February 21, 2002/ February 24, 2001/ Aug. 23, 2003/ February 5, 2009/No. 8832777
B. Claims subject to extension registration: Claim 1-3, 8, 10, 11, 14, 18 (hereinafter collectively referred to as “instant extension invention”) prior to the expiration date: Extension of the term of validity prior to the registration of extension: 8, 10-201/12/10-132/132982/20 March 201: 838 days: Extension of the term of validity prior to the expiration date: 838 days in cases of permission or registration under Article 31 or 42 of the Pharmaceutical Affairs Act;
C. The background and content of the product license of this case (hereinafter “instant license”) 1) Korea Hegel Co., Ltd. (hereinafter “Korea Hegel Co., Ltd.”) (hereinafter “Korea Hegel Co., Ltd.”) was established on March 23, 2013 by the Ministry of Food and Drug Safety, on the following grounds: (a) on June 10, 201, the product name of which was changed to “Teroman” upon the application for the instant license; (b) on the part of the product name of Korea Hegel Co., Ltd. (hereinafter “Korea Hegel”) at the time of the application for the instant license; (c) however, on the part of June 10, 2011, the product name was changed to “Teromanta”; and (d) on the part of the foregoing product name, the product name was changed to “Teromanta”; and (d) on the part of the Korea Food and Drug Administration, the product name was abolished on March 23, 2013.
For this convenience, the Korea Food and Drug Administration or the Ministry of Food and Drug Safety are all referred to as the "Food and Drug Administration."
marketing approval of drugs.